Skip to content

BEAMBE: what changed

BE 0782.795.443NACE 47.741, Retail sale of medical and orthopaedic goods, excluding prescription glasses and lensesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€1,004
2024 · €6,438-€7,442
Equity
€9,152
2024 · €10,156-€1,004
Cash
€8,542
2024 · €11,296-€2,754
Balance sheet total
€12,807
2024 · €14,189-€1,382

Largest movements

2024 to 2025
Assets
  • Cash -€2,754

    down €2,754 (-24.4%), from €11,296 to €8,542

    mainly Stocks and contracts (-€1,202) and Net result for the year (-€1,004)

  • Stocks and contracts +€1,202

    new in 2025: €1,202

  • Receivables within one year +€170

    up €170 (+5.9%), from €2,893 to €3,063

Equity and liabilities
  • Profit (loss) carried forward -€1,004

    down €1,004 (-17.8%), from €5,656 to €4,652

  • Other debts -€378

    down €378 (-15.6%), from €2,424 to €2,046

Income statement
  • Gross operating margin -€10,470

    down €10,470, from €9,552 to -€918

  • Taxes -€1,610

    no longer reported in 2025 (was €1,610)

  • Financial charges -€1,027

    down €1,027 (-92.3%), from €1,113 to €86

  • Other operating charges -€391

    no longer reported in 2025 (was €391)

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €6,438
Gross operating margin -€10,470
Other operating charges +€391
Financial charges +€1,027
Taxes +€1,610
Result 2025 -€1,004
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€2,754
Investment €0
Financing €0
Cash 2024 €11,296
Net result for the year -€1,004
Stocks and contracts -€1,202
Receivables within one year -€170
Other debts -€378
Cash 2025 €8,542
takes cash out
Every line side by side 25 lines
Line Code 2024 2025 Change %
Total assets 20/58 €14,189 €12,807 -€1,382 -9.7%
Current assets 29/58 €14,189 €12,807 -€1,382 -9.7%
Stocks and contracts in progress 3 - €1,202 +€1,202
Stocks 30/36 - €1,202 +€1,202
Amounts receivable within one year 40/41 €2,893 €3,063 +€170 +5.9%
Other amounts receivable 41 €2,893 €3,063 +€170 +5.9%
Cash at bank and in hand 54/58 €11,296 €8,542 -€2,754 -24.4%
Total equity and liabilities 10/49 €14,189 €12,807 -€1,382 -9.7%
Equity 10/15 €10,156 €9,152 -€1,004 -9.9%
Contributions 10/11 €4,500 €4,500 = 0.0%
Profit (loss) carried forward 14 €5,656 €4,652 -€1,004 -17.8%
Amounts payable 17/49 €4,034 €3,656 -€378 -9.4%
Amounts payable within one year 42/48 €4,034 €3,656 -€378 -9.4%
Taxes, remuneration and social security 45 €1,610 €1,610 = 0.0%
Taxes 450/3 €1,610 €1,610 = 0.0%
Other amounts payable 47/48 €2,424 €2,046 -€378 -15.6%
Other operating charges 640/8 €391 - -€391
Gross operating margin 9900 €9,552 -€918 -€10,470
Operating profit (loss) 9901 €9,161 -€918 -€10,079
Financial charges 65/66B €1,113 €86 -€1,027 -92.3%
Recurring financial charges 65 €1,113 €86 -€1,027 -92.3%
Profit (loss) for the period before taxes 9903 €8,048 -€1,004 -€9,052
Income taxes 67/77 €1,610 - -€1,610
Profit (loss) for the period 9904 €6,438 -€1,004 -€7,442
Profit (loss) for the period to be appropriated 9905 €6,438 -€1,004 -€7,442

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€9,840 to €11,946

Midpoint €10,717 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €9,152
Capitalised earnings €10,529 to €14,740
Indication €9,840 to €11,946

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€9,152
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€9,152

Capitalised earnings

net result for the year (9904)
2025
-€1,004
2024
€6,438
2023
-€1,011
2022
€228
Average result
€1,474
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€10,529 / €12,283 / €14,740

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.